Metastasis is the leading cause of cancer mortality. Functional and clinical studies have
documented diverse B-cell and antibody responses in cancer metastasis. The presence of B …

Background Inflammatory breast cancer (IBC) is a very aggressive and lethal subtype of
breast cancer that accounts for about 4 % of all breast cancers diagnosed in the United States. …

Background mTOR inhibition of aromatase inhibitor (AI)-resistant breast cancer is currently
under evaluation in the clinic. Everolimus/RAD001 (Afinitor®) has had limited efficacy as a …

Introduction Estrogen deprivation using aromatase inhibitors (AIs) is currently the standard
of care for postmenopausal women with hormone receptor-positive breast cancer. …

Interferon induced transmembrane protein 1 (IFITM1) belongs to a family of interferon
stimulated genes (ISGs) that is associated with tumor progression and DNA damage resistance; …

Background Prostate cancer risk stratification using single-nucleotide polymorphisms (SNPs)
demonstrates considerable promise in men of European, Asian, and African genetic …

Work over the past several decades has identified that aberrations in the ErbB signaling
pathways are key drivers of oncogenesis, and concurrent efforts to discover targetable …

Background In a recent phase III randomized control trial, delivering a focal radiotherapy (RT)
boost to tumors visible on MRI was shown to improve disease-free survival and regional/…

MUC1 and IFITM1 overexpression drives AI resistance and can be targeted with currently
available therapies. Visual Overview: http://mcr.aacrjournals.org/content/molcanres/17/5/1180/…

Overexpression of interferon induced transmembrane protein-1 (IFITM1) enhances tumor
progression in multiple cancers, but its role in triple-negative breast cancer (TNBC) is unknown…